CA
BNGO icon

Cliff Asness’s Bionano Genomics BNGO Stock Holding History

Cliff Asness’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-196
Closed -$352K – 2221
2021
Q4 		$352K Buy
196
+32
+20% +$85.6K ﹤0.01% 1935
2021
Q3 		$541K Buy
164
+102
+165% +$357K ﹤0.01% 1836
2021
Q2 		$273K Buy
+62
New +$245K ﹤0.01% 2063

Other funds holding BNGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank Julius Baer & Co
Bank Julius Baer & Co Zurich, Switzerland $38.6B AUM 35.31% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Cliff Asness's BNGO Position: Q1 2022 in Review

Cliff Asness sold out of Bionano Genomics (BNGO) in Q1 2022, closing a stake of 196 shares — an estimated $352K sold.

Cliff Asness first reported a position in BNGO in Q2 2021 and held it in 3 quarters. The position peaked at $541K in Q3 2021. 148 funds tracked by Wall St. Rank hold BNGO as of Q1 2022.

  • Cliff Asness reported no remaining Bionano Genomics position as of Q1 2022 after selling out during the quarter.
  • Cliff Asness sold 196 Bionano Genomics shares in Q1 2022, an estimated $352K.
  • Cliff Asness first reported a position in Bionano Genomics in Q2 2021 and held it in 3 quarters.
  • Cliff Asness's Bionano Genomics position peaked at $541K in Q3 2021.
  • 148 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2022.

Based on AQR Capital Management's 13F filing for Q1 2022, filed 16 May 2022.